PP_1170x120_10-25-21

Idrasil

C3 International introduces medical cannabis pill Idrasil

C3 International introduces medical cannabis pill Idrasil

GARDEN GROVE, Calif.– C3 International, a biopharmaceutical company that has played a leadership role in the emerging cannabinoid therapeutics health sector, officially announced the launch of its flagship Idrasil pain management pill. Idrasil is the first standardized form of medical cannabis. It offers all of the medicinal analgesic and therapeutic benefits of cannabis, but is

Adheris Health